Coeptis Therapeutics Holdings Inc Stock, NASDAQ:COEP
105 Bradford Road, Suite 420, Wexford, Pennsylvania 15090
United States of America
Number of Employees: 5
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company. It develops innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.